Funding
← Back to your selection

Angelini Ventures

angeliniventures.com ↗Activity from announced rounds

Activity in this selectionnaventures-afedbd2c

Angelini Ventures invests globally in biotechnology and health technology as the venture capital organization of Angelini Industries.

Investment focus

Its investment focus is on technologies that address unmet healthcare needs and improve patient journeys. The firm supports founders with capital, enterprise capabilities and connections across industry, research and investing.

Activity recorded by RoundOS

RoundOS records include Aptadir’s RNA therapeutics, Epicrispr’s epigenetic medicines, MMI’s robotic microsurgery and Handspring’s mental-health services. They show recorded activity across therapeutic development, medical devices and care delivery. The examples are a bounded selection from this database rather than the full Angelini Ventures portfolio.

Sources
Rounds participated in
4
Confirmed lead rounds
0
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$174M
4 disclosed · full round size, not this investor’s share

By stage

Growth1
Seed1
Series B1
Series C+1

By primary sector

Biotech2
Healthtech2

By country

Italy2
United States2

Rounds

4 in this selection
MMI

Medical Microinstruments (MMI) makes the Symani robotic microsurgery system for surgeons treating patients who need reconstructive microsurgery or supermicrosurgery. Its wristed instruments scale and steady surgeons’ hand movements for precise work on very small blood vessels and soft tissue.

€17M€17 million co-investment
Participant
Handspring

Provides evidence-based virtual mental health care to youth, young adults, and their families

$19MSeries B
Role not disclosed